摘要
心脏再同步化治疗是近年在慢性心力衰竭治疗领域的重要进展,但即使按照目前Ⅰ类推荐适应证入选治疗患者,仍有大约高达40%的患者没能从中获益,临床常称之为心脏再同步化治疗无应答或应答不良,现结合最新研究进展,分析其中原因,从入选适应证的优化选择、植入装置的程控优化及关键的左室电极放置诸方面给予综述。
Cardiac resynchronization therapy (CRT) is a very important development in the treatment of heart failure. However, there are up to 40% of patients who do not show a favorable response. Using current research, this review analyzes relevant options and discusses issues related to optimal indication selection, optimal programming device settings and pivotal left lead positioning.
出处
《心血管病学进展》
CAS
2012年第1期89-93,共5页
Advances in Cardiovascular Diseases
关键词
心脏再同步化治疗
应答
优化
cardiac resynchronization therapy
responders
optimization